Showing 1 - 10 results of 10 for search 'Poul Erik Braad', query time: 0.04s
Refine Results
-
1
Prognostic Value of Dual-Time-Point <sup>18</sup>F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures by Mohammad Naghavi-Behzad, Charlotte Bjerg Petersen, Marianne Vogsen, Poul-Erik Braad, Malene Grubbe Hildebrandt, Oke Gerke
Published 2020-06-01
Article -
2
Seeing the unseen--bioturbation in 4D: tracing bioirrigation in marine sediment using positron emission tomography and computed tomography. by Matthieu Delefosse, Erik Kristensen, Diane Crunelle, Poul Erik Braad, Johan Hygum Dam, Helge Thisgaard, Anders Thomassen, Poul Flemming Høilund-Carlsen
Published 2015-01-01
Article -
3
Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer by Jonas S. Sørensen, Mie H. Vilstrup, Jorun Holm, Marianne Vogsen, Jakob L. Bülow, Lasse Ljungstrøm, Poul-Erik Braad, Oke Gerke, Malene G. Hildebrandt
Published 2020-11-01
Article -
4
FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST by Marianne Vogsen, Jakob Lykke Bülow, Lasse Ljungstrøm, Hjalte Rasmus Oltmann, Tural Asgharzadeh Alamdari, Mohammad Naghavi-Behzad, Poul-Erik Braad, Oke Gerke, Malene Grubbe Hildebrandt
Published 2021-04-01
Article -
5
Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer by Mohammad Naghavi-Behzad, Hjalte Rasmus Oltmann, Tural Asgharzadeh Alamdari, Jakob Lykke Bülow, Lasse Ljungstrøm, Poul-Erik Braad, Jon Thor Asmussen, Marianne Vogsen, Annette Raskov Kodahl, Oke Gerke, Malene Grubbe Hildebrandt
Published 2021-08-01
Article -
6
Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study by Marianne Vogsen, Jeanette Dupont Jensen, Oke Gerke, Anne Marie Bak Jylling, Jon Thor Asmussen, Ivar Yannick Christensen, Poul-Erik Braad, Peter Thye-Rønn, Katrine Lydolph Søe, Marianne Ewertz, Malene Grubbe Hildebrandt
Published 2021-09-01
Article -
7
Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer by Mohammad Naghavi-Behzad, Marianne Vogsen, Oke Gerke, Sara Elisabeth Dahlsgaard-Wallenius, Henriette Juel Nissen, Nick Møldrup Jakobsen, Poul-Erik Braad, Mie Holm Vilstrup, Paul Deak, Malene Grubbe Hildebrandt, Thomas Lund Andersen
Published 2023-03-01
Article -
8
FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond by Malene Grubbe Hildebrandt, Jeppe Faurholdt Lauridsen, Marianne Vogsen, Jorun Holm, Mie Holm Vilstrup, Poul-Erik Braad, Oke Gerke, Mads Thomassen, Marianne Ewertz, Poul Flemming Høilund-Carlsen, The Centre for Personalized Response Monitoring in Oncology (PREMIO)
Published 2019-08-01
Article -
9
2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer by Marianne Vogsen, Mohammad Naghavi-Behzad, Frederik Graae Harbo, Nick Møldrup Jakobsen, Oke Gerke, Jon Thor Asmussen, Henriette Juel Nissen, Sara Elisabeth Dahlsgaard-Wallenius, Poul-Erik Braad, Jeanette Dupont Jensen, Marianne Ewertz, Malene Grubbe Hildebrandt
Published 2023-04-01
Article -
10
A randomised trial of [18F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol by Karen Middelbo Buch‐Olsen, Mads Hvid Poulsen, Steinbjørn Hansen, Mie Holm Vilstrup, Jorun Holm, Søren Hess, Paw Christian Holdgaard, Karsten Egbert Arnold Zieger, Søren Sørensen Madsen, Oke Gerke, Kasper Tholstrup Pedersen, Johan Hygum Dam, Niels Langkjær, Louise Dorner Østergaard, Jon Thor Asmussen, Poul Erik Braad, Birgitte Nørgaard, Matthias Eiber, Malene Grubbe Hildebrandt
Published 2023-09-01
Article